Kenya has unveiled a comprehensive package of reforms to strengthen pharmaceutical regulation, improve health supply chains, and eliminate counterfeit medicines as part of its broader commitment to achieving Universal Health Coverage (UHC).
The reforms were announced during the 21st Annual Scientific Conference of the Kenya Pharmaceutical Association (KPA), held in Mombasa under the theme “Enhancing Access to Quality, Safe and Affordable Health Products and Technologies for Sustainable Healthcare in Kenya.” The event marked 50 years of KPA’s service in advancing the country’s pharmaceutical sector.
At the forefront of the reform agenda is the Ministry of Health’s digital transformation programme, which includes the implementation of four critical systems: the National Product Catalogue, Drug Formularies, a National Logistics Management System, and a Track-and-Trace system. These tools are expected to curb the distribution of counterfeit medicines, enhance transparency, and streamline the management of health commodities nationwide.
The Ministry emphasized the vital role of pharmaceutical technologists and health professionals in achieving UHC. Their work in primary care, community pharmacy operations, and supply chain integrity is seen as pivotal to ensuring the rational use of medicines and improving patient outcomes.
Continuous professional development under the Taifa Care model is a cornerstone of the reforms, with a strong focus on aligning workforce competencies with international standards and the constitutional right to quality healthcare. All medicines dispensed under the Social Health Authority (SHA) will be approved by the Pharmacy and Poisons Board and administered exclusively by qualified professionals.
The Ministry reiterated its commitment to fighting fraud and malpractice in healthcare delivery, particularly within the SHA network. Ongoing regulatory reviews aim to protect patient safety, promote fairness in professional practice, and uphold the integrity of the healthcare system.
These efforts reflect a broader strategy to provide Kenyans with safe, affordable, and high-quality health products and technologies, while reinforcing regulatory oversight and accountability throughout the pharmaceutical supply chain. The conference gathered healthcare professionals and policymakers united in advancing a stronger, more resilient health sector.
